In clinical facilities across, these intrinsic subtypes of cancer are recognized in the presence of immune-histochemical molecules, like estrogen receptor (ER), progesterone receptor (PR), HER2 expression and Ki67 labelled index1,3. This evidence concerns the gene PGR and cancer.